Toraji Amano

800 total citations
29 papers, 407 citations indexed

About

Toraji Amano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Toraji Amano has authored 29 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Toraji Amano's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Toraji Amano is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Toraji Amano collaborates with scholars based in Japan and United States. Toraji Amano's co-authors include Hirotoshi Dosaka‐Akita, Satoshi Hirano, Ichiro Kinoshita, Yoshitsugu Nakanishi, Hiroshi Nishihara, Takahiro Tsuchikawa, Yutaka Hatanaka, Keisuke Okamura, Toru Nakamura and Toshiyuki Harada and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Toraji Amano

29 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toraji Amano Japan	14	165	149	140	89	64	29	407
Stjepko Pleština Croatia	12	116 0.7×	88 0.6×	96 0.7×	46 0.5×	56 0.9×	59	379
Salvatore Corallo Italy	12	225 1.4×	120 0.8×	118 0.8×	70 0.8×	47 0.7×	37	421
Nobuhide Kubo Japan	13	186 1.1×	181 1.2×	298 2.1×	99 1.1×	45 0.7×	26	608
Yuming Rong China	13	178 1.1×	105 0.7×	81 0.6×	124 1.4×	27 0.4×	43	350
Shinichi Yamauchi Japan	12	281 1.7×	124 0.8×	142 1.0×	56 0.6×	37 0.6×	75	540
Tatsuma Sakaguchi Japan	13	204 1.2×	176 1.2×	251 1.8×	52 0.6×	81 1.3×	75	529
Mengjie Jiang China	12	131 0.8×	91 0.6×	101 0.7×	30 0.3×	63 1.0×	35	381
Kewei Hu China	9	112 0.7×	112 0.8×	173 1.2×	76 0.9×	56 0.9×	16	444
Madoka Kataoka Japan	12	148 0.9×	148 1.0×	198 1.4×	28 0.3×	40 0.6×	58	542
Tadashi Uwagawa Japan	11	228 1.4×	117 0.8×	175 1.3×	52 0.6×	67 1.0×	51	384

Countries citing papers authored by Toraji Amano

Since Specialization

Citations

This map shows the geographic impact of Toraji Amano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toraji Amano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toraji Amano more than expected).

Fields of papers citing papers by Toraji Amano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toraji Amano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toraji Amano. The network helps show where Toraji Amano may publish in the future.

Co-authorship network of co-authors of Toraji Amano

This figure shows the co-authorship network connecting the top 25 collaborators of Toraji Amano. A scholar is included among the top collaborators of Toraji Amano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toraji Amano. Toraji Amano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mitamura, Takashi, Kanako C. Hatanaka, Yutaka Hatanaka, et al.. (2022). Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer. Pharmacogenomics and Personalized Medicine. Volume 15. 977–984. 3 indexed citations

Hatanaka, Kanako C., et al.. (2021). Genetic heterogeneity during breast cancer progression in young patients. The Breast. 60. 206–213. 2 indexed citations

Amano, Toraji, Hideyuki Hayashi, Takashi Takeshita, et al.. (2021). Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer. Scientific Reports. 11(1). 8109–8109. 6 indexed citations

Sunami, Kuniko, Yoichi Naito, Eriko Aimono, et al.. (2021). The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan. International Journal of Clinical Oncology. 26(3). 443–449. 24 indexed citations

Kamachi, Hirofumi, Shigenori Homma, Hideki Kawamura, et al.. (2020). Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial. BJS Open. 4(5). 804–810. 13 indexed citations

Fukumoto, Shinichi, Satoshi Oizumi, Masao Harada, et al.. (2020). A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703). Cancer Chemotherapy and Pharmacology. 86(1). 117–127. 3 indexed citations

Nakanishi, Yoshitsugu, Keisuke Okamura, Takahiro Tsuchikawa, et al.. (2020). Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas. Annals of Surgical Oncology. 27(11). 4171–4180. 23 indexed citations

Nakanishi, Yoshitsugu, Toraji Amano, Keisuke Okamura, et al.. (2020). Stratification of Postoperative Prognosis by Invasive Tumor Thickness in Perihilar Cholangiocarcinoma. Annals of Surgical Oncology. 28(4). 2001–2009. 7 indexed citations

Hayashi, Hideyuki, Shigeki Tanishima, Kyōkō Fujii, et al.. (2020). Clinical impact of a cancer genomic profiling test using an in‐house comprehensive targeted sequencing system. Cancer Science. 111(10). 3926–3937. 19 indexed citations

10.

Hayashi, Hideyuki, Shigeki Tanishima, Kyōkō Fujii, et al.. (2018). Genomic testing for pancreatic cancer in clinical practice as real-world evidence. Pancreatology. 18(6). 647–654. 27 indexed citations

11.

Harada, Toshiyuki, Toraji Amano, Tomoo Ikari, et al.. (2018). Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials. Frontiers in Pharmacology. 8. 972–972. 15 indexed citations

12.

Asahina, Hajime, Satoshi Oizumi, Masahiro Watanabe, et al.. (2017). A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002). Cancer Chemotherapy and Pharmacology. 80(5). 955–963. 11 indexed citations

13.

Urita, Atsushi, Tadanao Funakoshi, Toraji Amano, et al.. (2016). Predictive factors of long head of the biceps tendon disorders—the bicipital groove morphology and subscapularis tendon tear. Journal of Shoulder and Elbow Surgery. 25(3). 384–389. 30 indexed citations

14.

Nakanishi, Yoshitsugu, Takahiro Tsuchikawa, Keisuke Okamura, et al.. (2016). Risk factors for a high Comprehensive Complication Index score after major hepatectomy for biliary cancer: a study of 229 patients at a single institution. HPB. 18(9). 735–741. 27 indexed citations

15.

Kubo, Kimitoshi, Hiroshi Kawakami, Masaki Kuwatani, et al.. (2016). Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study. BMC Gastroenterology. 16(1). 65–65. 10 indexed citations

16.

Takeuchi, Satoshi, Jun Taguchi, Toraji Amano, et al.. (2011). A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy. SHILAP Revista de lepidopterología. 4(2). 260–266. 5 indexed citations

17.

Tanaka, Seiji, et al.. (2004). Double heterozygosity for a novel missense mutation of Ile304 to Asn in addition to the missense mutation His280 to Pro in the integrin β3gene as a cause of the absence of platelet αIIbβ3in Glanzmann's thrombasthenia. Journal of Thrombosis and Haemostasis. 3(1). 68–73. 5 indexed citations

18.

Harada, Toshiyuki, Toraji Amano, Etsuro Yamaguchi, et al.. (2002). Necrotizing Sarcoid Granulomatosis Presenting with Elevated Serum Soluble Interleukin-2 Receptor Levels. Respiration. 69(5). 468–470. 12 indexed citations

19.

Yoshimura, Keiji, et al.. (1994). The Regional Skin Temperature of Hand under Different Clothing Conditions.. The Annals of physiological anthropology. 13(6). 375–381. 2 indexed citations

20.

Mitomi, Toshio, Kazufumi Suzuki, K Nishiyama, et al.. (1989). [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum].. PubMed. 16(6). 2241–9. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact